Clinical Trial Update: RAFT-TAVR PACE: LBBAP vs. RVP Post-TAVR in Patients Requiring PPI [NA]

View source ↗

Summary

The RAFT-TAVR PACE trial (NCT06857201) has been withdrawn; it was evaluating left bundle branch area pacing versus right ventricular pacing after transcatheter …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrioventricular Block
• Heart Failure

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: High Degree Second Degree Atrioventricular Block, Complete Heart Block | NA | Status: WITHDRAWN